Last reviewed · How we verify
Blood puncture site
At a glance
| Generic name | Blood puncture site |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study (NA)
- Auto-immunity and Pulmonary Arterial Hypertension (NA)
- Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab (EARLY_PHASE1)
- Improving Exercise Capacity With a Tailored Physical Activity Intervention (NA)
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
- Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage
- Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars (NA)
- Effect of Modified Radial Artery Cannulation Site on IABP Monitoring Stability (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood puncture site CI brief — competitive landscape report
- Blood puncture site updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI